G25S (p.Gly25Ser) variant of KRT3 (Keratin, type II cytoskeletal 3)

G25S (p.Gly25Ser) in KRT3 (Keratin, type II cytoskeletal 3) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.23 / 1. The record also includes population frequency data and structural context.

G25S (p.Gly25Ser) variant details